Esketamine Combined With Pregabalin on CPSP in Spinal Patients.
Status:
Not yet recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
Chronic postsurgical pain has become one of the most common complications of surgery. The
quality of life will be impacted once the postsurgical patients are combined with persistent
pain. What's more, the postsurgical pain may increase other adverse outcomes. It's important
to find a better way to keep the postsurgical patients away from postoperative pain.
Esketamine and pregabalin have become potentially effective drugs on CPSP.